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Abstract
 
 
Objective: BK virus (BKV) infection after kidney 
transplantation has been a topic of great interest in 
the recent decade. Prospective screening studies 
have revealed that BKVN is principally an early com-
plication of renal transplantation occurring within the 
first post-transplant year in most cases. The aim of 
the present study was to observe the incidence of 
decoy cell viruria in renal transplant recipients. Fur-
thermore, correlation of decoy cell viruria with graft 
function was assessed.
Methods: This analytic cross-sectional study was 
conducted in the Transplant Center of Alzahra Hos-
pital, Isfahan, Iran between Jun 2014 and June 
2015. Clinical screening for polyomavirus infection 
was done by means of urine cytological evaluation 
for decoy cells. Urine samples were analyzed in 
three steps including 2-4 months after transplanta-
tion, three and six months later. 
Results: Thirty-three patients (22 male and 11 fe-
male) received kidney transplant from living do-
nors. The average of patients’ age was 41.9±12.83 
(range: 20-63 years). Peritoneal and hemodialysis 
were used for 15.6% and 84.4% of recipients. The 
occurrence of decoy cell viruria at the time of en-
rollment, 3 and 6 months later was found in 18.2%, 
10.7% and zero, respectively.
Conclusion: As urine cytology is easy to perform 
and of low cost, it is a useful tool for the investiga-
tion of active polyoma virus infection. Moreover, the 
findings advocate that the presence of decoy cells 
along with high creatinine is a better indicator of the 
virus presence.
Key words: BK Virus, Decoy Cell Viruria, 
Renal Transplantation, Renal Function
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Introduction
BK virus (BKV) infection after kidney transplantation has 
been a topic of great interest in the recent decade. Human 
polyoma viruses are the members of the papova virus 
family which have a double strand DNA genome. The 
most identified species of this kind are BK-virus, JC-virus 
(JCV) and Simian-virus. BKV was first isolated from the 
urine of a renal transplant recipient with ureteric stenosis 
in 1971, but until 20 years later BKV was not recognized 
as a reason of interstitial nephritis and allograft failure in 
renal transplant patients. The preliminary infection may 
occur through fecal-oral transmission, respiratory tract and 
over the placenta. Also, they can be transmitted through 
organ transplantation. The vast majority of polyomavirus 
associated nephropathy (PVN) is triggered by the BKV, 
and the JCV is responsible for less than 3% of cases. (1)
BKV nephropathy (BKVN) which is involving 1-7% of 
renal transplant recipients, presented as a slow increase 
of serum creatinine. Prospective screening studies have 
revealed that BKVN is principally an early complication 
of renal transplantation occurring within the first post-
transplant year in most cases. (2) Although the pathological 
view of tubulointerstitial nephritis can mimic rejection, the 
treatments for these two conditions are dissimilar: While 
dose reduction of immunosuppressant is the treatment 
of tubulointerstitial nephritis, treatment of rejection is by 
increase in immunosuppressant dose. (3)
As BKVN has restricted treatment options, the goal of 
screening is to facilitate primary diagnosis of patients when 
viruric or viremic, and to interfere before the development 
of overt nephropathy. After BK recurrence, the virus is 
first detectable in the urine, however, viremia develops 
after several weeks. Despite guidelines recommending 
quantitative polymerase chain reaction (PCR) for 
screening, urinary decoy cell detection is a potentially 
cost-effective alternative. (4) The aim of the present study 
was to observe the incidence of decoy cell viruria in renal 
transplant recipients. Furthermore, correlation of decoy 
cell viruria with graft function was assessed.
Methods and Materials
Recruiting patients 
This analytic cross-sectional study was conducted in 
the Transplant Center of Alzahra hospital, Isfahan, Iran 
between Jun 2014 and June 2015. Ethical approval was 
attained from the local research ethics committee in 
school of medicine, Isfahan University of Isfahan before 
enrollment. (Approval code: IR.MUI.REC.1393.3030367, 
research project code: 393367) Informed written consent 
was obtained from all cases before recruiting in the study. 
Consecutive kidney transplant recipients from living donors 
who were older than 18 years were included. The inclusion 
criteria were to pass 1-4 months from transplantation. 
Patients who had a positive history of acute renal rejection 
or urothelial cancers were excluded. Also, patients were 
excluded from the study if they were unable to continue 
due to any causes. In all patients a comprehensive 
questionnaire including recipient demographic features, 
past drug history, concomitant diseases, type and duration 
of dialysis and time after transplant were recorded.
Laboratory tests
Clinical screening for polyomavirus infection was done 
by means of urine cytological evaluation for decoy cells. 
Urine samples were analyzed in three steps including 2-4 
months after transplantation, three and six months later. 
Early in the morning the patient voided the urine collected 
in the bladder overnight; the next fresh urine sample 
was referred to cytology laboratory within 15 minutes of 
micturition; 0.5-1 mL of urine was processed by liquid 
based cytology. Slides were immediately fixed in 95% 
alcohol for Papanicolaou staining. Time interval between 
the day of transplantation and first appearance of decoy 
cells in the urine and period of decoy cell persistence in 
the urine were assessed. Also, the number of decoy cells 
was counted in each smear. Qualitative urine and blood 
PCR for BKV DNA performed for patients were positive for 
presence of decoy cells in their urine cytology. Moreover, 
urine analysis was performed for all patients. Urine cytology 
was performed at 3 and 6 months after the first evaluation. 
Simultaneously, in order to assess renal function, serum 
creatinine was measured three times. Since GFR is 
considered as a highly sensitive and specific scale for 
chronic renal failure, it was calculated by MDRD formula 
based on serum creatinine. Transplant kidney biopsy was 
performed considering medical indications approved by 
expert nephrologist (5).
Statistical analysis
All data were analyzed using the SPSS®23 statistical 
software package. Quantitative demographic characteristics 
are expressed as mean ± standard deviation (SD) and 
qualitative data are shown as a percentage. To compare 
means of two normally distributed data, the Student’s t-
test was used. For non-normally distributed data, the 
Mann-Whitney U-test was used. For comparisons of the 
correlations between the two groups, the chi-square and 
Fisher’s exact tests were used. A p-value of <0.05 was 
considered statistically significant.
Results
Demographic data
Thirty-three patients (22 male and 11 female) received 
kidney transplant from living donors. The average of 
patients’ age was 41.9±12.83 (range: 20-63 years). 
Peritoneal and hemodialysis were used for 15.6% and 
84.4% of recipients. After transplantation, patients received 
prednisone, cyclosporine, and mycophenolate mofetil. 
The average of months of interval between transplantation 
and the first assessment was 2±0.9 months (range: 1-
4). Demographic, clinical and para-clinical information of 
transplant recipients are revealed in Table 1.
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Table 1: Demographic, Clinical & Paraclinical Information of Transplant Recipients Revealed
Figure 1: Plots of creatinine (a) and GFR (b)in three consecutive samplings 
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Table 2: Decoy Cell Per Smear 
 
Figure 2: Decoy cells with enlarged nucleus with a baso-philic intra-nuclear inclusion (papanicolaou stain *400)
Occurrence of decoy cell viruria 
Urine decoy cells were assessed in three mentioned 
intervals (at the time of enrollment, 3 and 6 months later). 
Definite presence of decoy cell, was proved by qualitative 
PCR of urine in all cases with positive sample (Figure 1). The 
occurrence of decoy cell viruria at the time of enrollment, 
3 and 6 month later was found in 18.2%, 10.7% and zero, 
respectively. One case with decoy cell viruria and positive 
for CMV and BK-PCR underwent renal biopsy and showed 
no viral changes. The number of decoy cells in each high 
power field is shown in Table 1.
Evaluation of renal function
Serum creatinine and urine analysis were used for the 
evaluation of renal function. The level of creatinine was 
1.43±0.29 mg/dL, 1.39±0.24 mg/dL and 1.35±0.26 mg/
dL in the three steps of the survey. Also, estimated GFR 
(eGFR) was calculated using the MDRD formula. In three 
steps of follow up the value of eGFR was 55.3±11.4 mls/
min/1.73m2, 57.3±11.7 mls/min/1.73m2 and 61.8±14.3mls/
min/1.73m2. The urinary WBC count was 8.0±10.4, 7.4±4.1 
and 6.7±3.3 in three intervals. Moreover, the urinary count 
of RBC was 23.3±17.7, 9.2±3.4 and 2.1±1.6 respectively.
Correlation of decoy cell viruria and renal function
Independent t-test demonstrated that there is a significant 
difference between renal function and decoy cell viruria 
after 2 months of follow up. (P= 0.017) Moreover, the count 
of RBC was significantly lower in patients with decoy cell 
viruria (P= 0.001). After 5 months of follow up the level of 
creatinine was significantly higher in patients with decoy 
cell viruria (0.3±0.17 vs 0.2±0.04). Results of Spearman’s 
rho test are demonstrated in Table 2. Regarding all of the 
93 samples the level of creatinine was significantly higher 
in patients with decoy cel viruria. Additionally, there was 
no significant difference between occurrence of decoy 
cell viruria and count of WBC and RBC. In order to make 
a better correlation between decoy cell viruria and renal 
function, we divided patients into two groups, including 
GFR lower than 60 (group A) and larger and equal to 60 
(group B). The average of patients’ age in group A was 
significantly higher than group B (46.2±11.5 vs 36.2±12, 
P<0.001).
The GFR of groups A and B were 65±13 and 56±9 
respectively and they were significantly different. Male 
patients were significantly more in group A rather than 
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females. 89% of patients with positive decoy cell viruria 
were in group A, while 60.2% of patients without decoy 
cell viruria were in this group (P=0.039). Since there was 
a significant correlation between post-transplantation 
GFR and age, sex and pre-transplantation GFR, we 
used logistic regression test to control their confounding 
effect. According to this, we concluded that there was a 
significant correlation between post-transplantation GFR 
and positivity for decoy cell viruria (OR=11.6; 95% CIs 
1.12-120.04, p=0.02) (Figure 2).
Discussion
One of the leading causes of graft loss after kidney 
transplantation is polyomavirus. JC and BK virus infection 
is very prevalent in the first two years after transplant and 
might be monitored appropriately (6). Routine screening for 
BK has been shown to be effective in preventing allograft 
loss in patients with BK viruria or viremia. Reduction 
of immunosuppression remains the mainstay of BK 
nephropathy treatment and is the best studied intervention 
(7). The present study was conducted on thirty-three 
patients (22 males and 11 females) who received kidney 
transplantation from living donors. The average of patients’ 
age was 41.9±12.83 (range: 20-63) years. In a similar 
study in Iran thirty-one patients (21 men and 10 women) 
received kidney transplant from living donors. In this study, 
the average of patients’ age was 38.3±12.8 (rage: 17-59) 
years (8). Urine cytology is a safe, noninvasive and sensitive 
tool for the evaluation and follow-up of renal transplant 
recipients and can be used as prospective screening for 
BKV allograft nephropathy (9). In BKV nephropathy, the 
finding of urinary decoy cells showed a 100% sensitivity, 
84% specificity, 100% negative predictive value and 6% 
positive predictive value (10). In the first step of follow up of 
our study, the presence of decoy cells was 18.2% in kidney 
transplant recipients, while another report demonstrated 
the presence of decoy cells in 37.5% of patients (8). 
In this study, the occurrence of decoy cell viruria at the 
time of enrollment, and 3 and 6 months later was 18.2%, 
10.7% and zero, respectively. Moreover, in another study 
the prevalence of polyoma virus infections increased with 
increasing time after transplantation (11), which is similar 
to the study by Liu et al. (12) Another same study revealed 
that Urinary decoy cell shedding was detected in 26.2% 
of 286 cases. BKV viruria was observed in 22.1% of 938 
cases and BKV viremia in 5.2% of 1,029 cases. (13) One 
study in 2007, presented that significant polyoma viruses 
viruria is common following renal transplantation with onset 
usually within the first 3 months. Viruria is associated with 
worse graft function at 3 and 6 months. The time between 
urine positivity and clinical polyoma virus nephropathy 
is short. More frequent early urine screening would be 
required to achieve clinical benefit. In another study, the 
incidences of viruria and viremia at 1 year were 35% and 
11.5%, respectively, compared with 17% and 3% at a time 
of 49 months post-transplantation.(10) Although managing 
a BKV infection includes reducing immunosuppression 
alone or combined with antiviral therapy, such as cidofovir 
or leflunomide, only an early diagnosis and reduction of 
immunosuppression reliably improve graft survival. (13)
The present study also revealed that the level of plasma 
creatinine was significantly higher in patients with decoy 
cell viruria. This correlation is similar to another study 
demonstrating that patients with BK-virus nephropathy had 
high serum creatinine that mimicked either tubular necrosis 
or rejection (14). The same study in 2006, suggested that 
the presence of decoy cells along with high creatinine is 
a better indicator of the virus presence. According to this 
study, there was a significant correlation between post-
transplantation GFR and positivity for decoy cell viruria. 
Despite a low positive predictive value of decoy cells in 
urine, its absence has a negative predictive value of 100%, 
because almost all of those patients who did not have 
decoy cells had normal renal function.
 
Conclusion
In conclusion, our findings suggest that considering the 
risk of graft loss due to polyoma virus infection, routine 
urine cytology might be used as a screening method for 
the detection of polyoma virus infection. As urine cytology 
is easy to perform and of low cost, it is a useful tool for the 
investigation of active polyoma virus infection. Moreover, 
the findings advocate that the presence of decoy cells 
along with high creatinine is a better indicator of the virus 
presence (15).
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